Vapotherm Is Pleased to Announce New Partnership

EXETER, NH, July 12, 2016 – Vapotherm is pleased to announce a partnership with The FACES Foundation (Family and Caregiver Education & Support).

FACES is a national 501(c)(3) nonprofit organization whose mission is to acknowledge and promote professional excellence in the education and care of patients with pulmonary illnesses. Established in 2006 in memory of Philip C. Lamka, who passed away as a result of complications from an Interstitial Lung Disease (ILD), FACES believes that professional excellence leads to improved healthcare outcomes among patients living with pulmonary illnesses. Vapotherm has awarded FACES a charitable grant in support of The PHIL Award (Pulmonary Health and Illnesses of the Lungs).

The PHIL Award is FACES signature program. It is the only national award that recognizes outstanding respiratory therapists who provide exemplary care and treatment for patients with respiratory illnesses, as nominated by patients, family members, and other caregivers. Once a year, FACES’ hospital partners across the country present The PHIL Award to an outstanding respiratory therapist. In addition to being known throughout the country as ‘the best of the best’ in respiratory care, PHIL Award recipients receive the Appreciation sculpture from FACES. It illuminates the relationship between the RT and the patient. In support of the importance of continuing education, the honoree also receives paid tuition from FACES to their state’s annual professional conference.

Vapotherm is excited and proud to partner with such an incredible program that has such a powerful and strong mission. To learn more about FACES, please visit their website at

Vapotherm, Inc. is a privately held developer and manufacturer of advanced respiratory care technology based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 1,000,000 patients have been treated with Vapotherm High Flow Therapy. For more information, visit

Contact: Lise Halpern, VP Marketing & Clinicals (603) 658-0011

2017-04-07T01:33:59-04:00Jul 12|Vapotherm Company News|
Go to Top